389 related articles for article (PubMed ID: 18536030)
21. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck.
Pytynia KB; Grant JR; Etzel CJ; Roberts DB; Wei Q; Sturgis EM
J Clin Oncol; 2004 Oct; 22(19):3981-8. PubMed ID: 15459221
[TBL] [Abstract][Full Text] [Related]
22. p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer.
Geisler SA; Olshan AF; Weissler MC; Cai J; Funkhouser WK; Smith J; Vick K
Clin Cancer Res; 2002 Nov; 8(11):3445-53. PubMed ID: 12429633
[TBL] [Abstract][Full Text] [Related]
23. Plasma osteopontin is an independent prognostic marker for head and neck cancers.
Petrik D; Lavori PW; Cao H; Zhu Y; Wong P; Christofferson E; Kaplan MJ; Pinto HA; Sutphin P; Koong AC; Giaccia AJ; Le QT
J Clin Oncol; 2006 Nov; 24(33):5291-7. PubMed ID: 17114663
[TBL] [Abstract][Full Text] [Related]
24. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.
George DJ; Halabi S; Shepard TF; Sanford B; Vogelzang NJ; Small EJ; Kantoff PW
Clin Cancer Res; 2005 Mar; 11(5):1815-20. PubMed ID: 15756004
[TBL] [Abstract][Full Text] [Related]
26. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma.
Druzgal CH; Chen Z; Yeh NT; Thomas GR; Ondrey FG; Duffey DC; Vilela RJ; Ende K; McCullagh L; Rudy SF; Muir C; Herscher LL; Morris JC; Albert PS; Van Waes C
Head Neck; 2005 Sep; 27(9):771-84. PubMed ID: 15920746
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie.
Negrier S; Perol D; Menetrier-Caux C; Escudier B; Pallardy M; Ravaud A; Douillard JY; Chevreau C; Lasset C; Blay JY;
J Clin Oncol; 2004 Jun; 22(12):2371-8. PubMed ID: 15197198
[TBL] [Abstract][Full Text] [Related]
28. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
[TBL] [Abstract][Full Text] [Related]
29. Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse.
Liu SA; Wong YK; Lin JC; Poon CK; Tung KC; Tsai WC
Otolaryngol Head Neck Surg; 2007 Jan; 136(1):112-8. PubMed ID: 17210345
[TBL] [Abstract][Full Text] [Related]
30. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival.
Oddone N; Morgan GJ; Palme CE; Perera L; Shannon J; Wong E; Gebski V; Veness MJ
Cancer; 2009 May; 115(9):1883-91. PubMed ID: 19224549
[TBL] [Abstract][Full Text] [Related]
31. Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma.
Liao CT; Tung-Chieh Chang J; Wang HM; Chen IH; Lin CY; Chen TM; Hsieh LL; Cheng AJ
Head Neck; 2004 Jun; 26(6):504-12. PubMed ID: 15162351
[TBL] [Abstract][Full Text] [Related]
32. Serum prognostic markers in head and neck cancer.
Meyer F; Samson E; Douville P; Duchesne T; Liu G; Bairati I
Clin Cancer Res; 2010 Feb; 16(3):1008-15. PubMed ID: 20103685
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
[TBL] [Abstract][Full Text] [Related]
34. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ
J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
Siddiqui F; Pajak TF; Watkins-Bruner D; Konski AA; Coyne JC; Gwede CK; Garden AS; Spencer SA; Jones C; Movsas B
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):353-60. PubMed ID: 17889449
[TBL] [Abstract][Full Text] [Related]
36. Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: a clinician's guide.
Porceddu SV; Sidhom M; Foote M; Burmeister E; Stoneley A; El Hawwari B; Milross C; Kenny L; Poulsen M; Coman WB
J Med Imaging Radiat Oncol; 2008 Oct; 52(5):491-6. PubMed ID: 19032396
[TBL] [Abstract][Full Text] [Related]
37. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies.
De Vita F; Orditura M; Galizia G; Romano C; Infusino S; Auriemma A; Lieto E; Catalano G
Cancer; 1999 Nov; 86(10):1936-43. PubMed ID: 10570416
[TBL] [Abstract][Full Text] [Related]
38. Quality of life scores predict survival among patients with head and neck cancer.
Karvonen-Gutierrez CA; Ronis DL; Fowler KE; Terrell JE; Gruber SB; Duffy SA
J Clin Oncol; 2008 Jun; 26(16):2754-60. PubMed ID: 18509185
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.
Sackett MK; Bairati I; Meyer F; Jobin E; Lussier S; Fortin A; Gélinas M; Nabid A; Brochet F; Têtu B
Clin Cancer Res; 2008 Jan; 14(1):67-73. PubMed ID: 18172254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
